Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements

Journal of Immunological Methods

Volumn 238, Issue 1-2, 2000, Pages 119-131

  Duperrier, Karine ^a   Eljaafari, Assia ^a,b   Dezutter Dambuyant, Colette ^c   Bardin, Christine ^a   Jacquet, Christelle ^c   Yoneda, Koyo ^d   Schmitt, Daniel ^c   Gebuhrer, Lucette ^a   Rigal, Dominique ^a,b  

^a Etablissement de Transfus Sanguine   (France)

^b UNIVERSITÉ LYON 1   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Cellular therapy; Dermal dendritic cells; Monocytes; Serum

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD 14 ANTIGEN; CD 1A ANTIGEN; CD 54 ANTIGEN; CD 80 ANTIGEN; CD 83 ANTIGEN; CD 86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MIXED LYMPHOCYTE REACTION; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SERUM;

ANTIGENS, CD1; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA; DENDRITIC CELLS; DERMIS; HUMANS; MICROSCOPY, ELECTRON; MONOCYTES; SERUM ALBUMIN, BOVINE; TRANSGLUTAMINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034697388     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00147-2     Document Type: Article

References (26)

1. Bender A., Sapp M., Schuler G., Steinman R.M., Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods. 196:1996;121.
2. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF-α J. Exp. Med. 184:1996;695.
3. Caux C., Massacrier C., Vanbervliet B., Dubois B., Durand I., Cella M., Lanzavecchia A., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF-α: II. Functional analysis. Blood. 90:1997;1458.
4. Croft M., Duncan D.D., Swain S.L. Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements. J. Exp. Med. 176:1992;1431.
5. Eljaafari A., Duperrier K., Mazet S., Bardin C., Bernaud J., Durand B., Gebuhrer L., Betuel H., Rigal D. Generation of stable monocyte-derived dendritic cells in the presence of high concentrations of homologous or autologous serum: influence of extra-cellular pH. Hum. Immunol. 59:1998;625.
6. Grassi F., Dezutter-Dambuyant C., McIlroy D., Jacquet C., Yoneda K., Imamura S., Boumsell L., Schmitt D., Autran B., Debre P., Hosmalin A. Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J. Leukocyte Biol. 64:1998;484.
7. Grouard G., Durand I., Filgueira L., Banchereau J., Liu Y.J. Dendritic cells capable of stimulating T cells in germinal centers. Nature. 384:1996;364.
8. Hart D.N.J. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 90:1997;3245.
9. Holtl L., Rieser C., Papesh C., Ramoner R., Bartsch G., Thurnher M. CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer. Lancet. 352:1998;1358.
10. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engleman E.G., Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:1996;52.
11. Inaba K., Schuler G., Witmer M.D., Valinsky J., Atassi B., Steinman R.M. Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J. Exp. Med. 164:1986;605.
12. Kashihara M., Ueda M., Horiguchi Y., Furukawa F., Hanaoka M., Imamura S. A monoclonal antibody specifically reactive to human Langerhans cells evidenced by immunogoldrelabelling. J. Invest. Dermatol. 92:1986;217.
13. Mannering S.I., McKenzie J.L., Hart D.N.J. Optimisation of the conditions for generating human DC initiated antigen specific T lymphocyte lines in vitro. J. Immunol. Methods. 219:1998;69.
14. McLellan A.D., Heiser A., Sorg R.V., Fearnley D.B., Hart D.N.J. Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype. J. Invest. Dermatol. 111:1998;841.
15. Nestle F.O., Zheng X.-G., Thompson C.B., Turka L.A., Nickoloff B.J. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 151:1993;6535.
16. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:1998;328.
17. Pickl W.F., Majdic O., Kohl P., Stockl J., Riedl E., Scheinecker C., Bello-Fernandez C., Knapp W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol. 157:1996;3850.
18. Romani N., Koide S., Crowley M., Witmer-Pack M., Livingstone A.M., Fathman C.G., Inaba K., Steinman R.M. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature epidermal Langerhans cells. J. Exp. Med. 169:1989;1169.
19. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods. 196:1996;137.
20. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J. Exp. Med. 179:1994;1109.
21. Steinbach F., Krause B., Bläß S., Burmester G.-R., Hiepe F. Development of accessory phenotype and function during the differentiation of monocyte-derived dendritic cells. Res. Immunol. 149:1998;627.
22. Steinman R.M., Nussenzweig M.C. Dendritic cells: features and functions. Immunol. Rev. 53:1980;127.
23. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271.
24. Steinman R.M., Hoffman L., Pope M. Maturation and migration of cutaneous dendritic cells. J. Invest. Dermatol. 105:1995;2S.
25. Suri R.M., Austyn J.M. Bacterial lipopolysaccharide contamination of commercial collagen preparations may mediate dendritic cell maturation in culture. J. Immunol. Methods. 214:1998;149.
26. Tew J.G., Wu J., Qin D., Helm S., Burton G.J., Szakal A.K. Follicular dendritic cells and presentation of antigen and co-stimulatory signals to B cells. Immunol. Rev. 156:1997;39.